Short Interest in Bioxytran, Inc. (OTCMKTS:BIXT) Grows By 2,418.3%

Bioxytran, Inc. (OTCMKTS:BIXT) was the recipient of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 10,300 shares, a growth of 2,418.3% from the February 12th total of 409 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 481,876 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 481,876 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are short sold.

Bioxytran Price Performance

Shares of BIXT opened at $0.04 on Wednesday. Bioxytran has a 1-year low of $0.03 and a 1-year high of $0.23. The stock has a market cap of $4.75 million, a PE ratio of -1.40 and a beta of 2.14. The firm has a fifty day moving average price of $0.05 and a 200 day moving average price of $0.07.

Bioxytran Company Profile

Bioxytran, Inc is a clinical-stage biotechnology company focused on the development of synthetic oxygen carriers and novel oxygen therapeutics for acute care and chronic disease applications. The company’s proprietary platform is designed to safely deliver therapeutic levels of oxygen to hypoxic tissues, addressing conditions such as ischemia-reperfusion injury, organ transplantation, and traumatic injury. Its lead product candidates target unmet medical needs in cardiovascular and neurological disorders, wound healing, and critical care settings.

Bioxytran’s research pipeline comprises multiple preclinical-stage assets that leverage stabilized perfluorocarbon emulsions to achieve controlled oxygen release.